BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37832863)

  • 1. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM
    Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.
    Ansari MA; Nadeem A; Alshammari MA; Attia SM; Bakheet SA; Khan MR; Albekairi TH; Alasmari AF; Alhosaini K; Alqahtani F; Al-Mazroua HA; Ahmad SF
    Exp Neurol; 2022 May; 351():113997. PubMed ID: 35122866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM
    Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance.
    Aldossari AA; Assiri MA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Albekairi TH; Alomar HA; Al-Mazroua HA; Almanaa TN; Al-Hamamah MA; Alwetaid MY; Ahmad SF
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC chemokine receptor 5 antagonist alleviates inflammation by regulating IFN-γ/IL-10 and STAT4/Smad3 signaling in a mouse model of autoimmune encephalomyelitis.
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Shahid M; Al-Mazroua HA; As Sobeai HM; Alasmari AF; Alanazi MM; Alhamed AS; Aldossari AA; Attia SM
    Cell Immunol; 2022 Sep; 379():104580. PubMed ID: 35872534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery.
    Al-Mazroua HA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Albekairi TH; Ali N; Alasmari F; Algahtani M; Alsaad AMS; Ahmad SF
    Mol Immunol; 2022 Apr; 144():127-137. PubMed ID: 35219910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th17 cell promotes apoptosis of IL-23R
    Sonar SA; Meitei HT; Karmakar S; Mishra A; Inamdar S; Lenka N; Lal G
    Clin Immunol; 2024 Feb; 259():109898. PubMed ID: 38185267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
    Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
    Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
    Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
    Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
    Reppert S; Zinser E; Holzinger C; Sandrock L; Koch S; Finotto S
    Eur J Immunol; 2015 May; 45(5):1426-40. PubMed ID: 25689841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alotaibi MR; Alasmari AF; Alshammari MA; Al-Mazroua HA; Attia SM
    Eur J Pharmacol; 2019 Mar; 846():100-108. PubMed ID: 30658114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL/J mice through the inhibition of nuclear factor-kappa B signaling in B cells.
    Alomar HA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Al-Mazroua HA; Alhazzani K; Assiri MA; Alqinyah M; Almudimeegh S; Ahmad SF
    Brain Res Bull; 2023 Mar; 194():45-53. PubMed ID: 36646144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T
    Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF
    Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity.
    Yang Y; Winger RC; Lee PW; Nuro-Gyina PK; Minc A; Larson M; Liu Y; Pei W; Rieser E; Racke MK; Lovett-Racke AE
    Clin Exp Immunol; 2015 Jan; 179(1):108-18. PubMed ID: 25142403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PG201 protects mice from experimental autoimmune encephalomyelitis via suppression of effector T cell activation.
    Bae MJ; Choi J; Kim HK; Lim S; Kim S
    Phytomedicine; 2018 Apr; 43():150-157. PubMed ID: 29747748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.